"Valet available at 6620 Main Street General Parking is located on 1831 Southgate Blvd"

During the past decade, Baylor Clinic conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 7 clinical trials were completed, i.e. on average, 77.8% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Baylor Clinic" #1 sponsor was "Baylor College of Medicine" with 4 trials, followed by "Actelion" with 2 trials sponsored, "Novartis" with 2 trials sponsored, "Seagen Inc." with 2 trials sponsored and "APT Pharmaceuticals, Inc." with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Baylor Clinic" #1 collaborator was "Center for Cell and Gene Therapy, Baylor College of Medicine" with 1 trials as a collaborator, "Harris County Hospital District" with 1 trials as a collaborator, "Merck Sharp & Dohme LLC" with 1 trials as a collaborator, "National Institute of Nursing Research (NINR)" with 1 trials as a collaborator and "Pancreatic Cancer Action Network" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Baylor Clinic" are "Diabetes Mellitus, Type 2" (2 trials), "Idiopathic Pulmonary Fibrosis" (2 trials), "Irritable Bowel Syndrome" (2 trials), "Atherosclerosis" (1 trials) and "Bladder Cancer" (1 trials). Many other conditions were trialed in "Baylor Clinic" in a lesser frequency.

Most popular intervention types in "Baylor Clinic" are "Drug" (17 trials), "Biological" (2 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "placebo" (3 trials), "Gemcitabine" (2 trials), "tucatinib" (2 trials) and "vildagliptin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Baylor Clinic" are 18 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Baylor Clinic". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Baylor Clinic, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Baylor Clinic, 3 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".